CSIMarket Company Name, Ticker, Competitors, else..
 
Jade Biosciences Inc   (NASDAQ: JBIO)
 
Price: $21.1350 $-0.23 -1.053%
Day's High: $21.55500030517578 Week Perf: -0.91 %
Day's Low: $ 20.73 30 Day Perf: 10.37 %
Volume (M): 139,413 52 Wk High: $ 28.00
Volume (M$): $ 0 52 Wk Avg: $16.00
Open: $21.32 52 Wk Low: $6.91



 Market Capitalization (Millions $) 1,290
 Shares Outstanding (Millions) 61
 Employees 55
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -189
 Cash Flow (TTM) (Millions $) -116
 Capital Exp. (TTM) (Millions $) 0

Business Description


The company is a clinical-stage biopharmaceutical firm developing biologic therapies for autoimmune diseases. Its lead product candidates include JADE101, a monoclonal antibody targeting APRIL for IgA nephropathy; JADE201, targeting BAFF-R for multiple autoimmune disorders; and JADE301, targeting an undisclosed pathway. These candidates are in various stages of clinical development.


   Company Address: 221 Crescent Street Waltham 2453 MA
   Company Phone Number: 312-3013   Stock Exchange / Ticker: NASDAQ JBIO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clinical Study

Advancing the Frontier of Renal Therapy JADE101’s Promising Data Unveiled at Kidney Week 2025

Published Mon, Oct 20 2025 8:47 AM UTC

: Jade Biosciences has recently unveiled noteworthy data concerning its investigative therapeutic agent, JADE101, at the American Society of Nephrology’s Annual Kidney Week 2025. This cutting-edge therapy shows potential in addressing critical unmet needs within nephrology, offering hope to countless patients suffering from kidney diseases. This report provides a detailed ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 2.93
PEG (TTM) -

Financial Strength Current
Quick Ratio 14.61
Working Capital Ratio 14.93
Leverage Ratio (MRQ) 0.07
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -2.15 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 7.55 $
Book Value 7.21 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -3,434,382
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.